Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
blog-list-cover
Recent blog posts
GPR15 Biologics Sequence Review Report 2026: G protein-coupled receptor 15 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
GPR15 Biologics Sequence Review Report 2026: G protein-coupled receptor 15 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of GPR15 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
GPR12 Biologics Sequence Review Report 2026: G protein-coupled receptor 12 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
GPR12 Biologics Sequence Review Report 2026: G protein-coupled receptor 12 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of GPR12 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
GPR6 Biologics Sequence Review Report 2026: G protein-coupled receptor 6 Similarity and Patent-Risk Signals
8 min read
GPR6 Biologics Sequence Review Report 2026: G protein-coupled receptor 6 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of GPR6 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
GPR4 Biologics Sequence Review Report 2026: G protein-coupled receptor 4 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
GPR4 Biologics Sequence Review Report 2026: G protein-coupled receptor 4 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of GPR4 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
GPR3 Biologics Sequence Review Report 2026: G protein-coupled receptor 3 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
GPR3 Biologics Sequence Review Report 2026: G protein-coupled receptor 3 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of GPR3 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
GPR183 Biologics Sequence Review Report 2026: G protein-coupled receptor 183 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
GPR183 Biologics Sequence Review Report 2026: G protein-coupled receptor 183 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of GPR183 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
TNFRSF8 Biologics Sequence Review Report 2026: Tumor necrosis factor receptor superfamily member 8 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
TNFRSF8 Biologics Sequence Review Report 2026: Tumor necrosis factor receptor superfamily member 8 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of TNFRSF8 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
PTPRM Biologics Sequence Review Report 2026: Receptor-type tyrosine-protein phosphatase mu Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
PTPRM Biologics Sequence Review Report 2026: Receptor-type tyrosine-protein phosphatase mu Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of PTPRM protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
KLRK1 Biologics Sequence Review Report 2026: NKG2-D type II integral membrane protein Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
KLRK1 Biologics Sequence Review Report 2026: NKG2-D type II integral membrane protein Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of KLRK1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
KLRC2 Biologics Sequence Review Report 2026: NKG2-C type II integral membrane protein Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
KLRC2 Biologics Sequence Review Report 2026: NKG2-C type II integral membrane protein Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of KLRC2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
KLRC1 Biologics Sequence Review Report 2026: NKG2-A/NKG2-B type II integral membrane protein Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
KLRC1 Biologics Sequence Review Report 2026: NKG2-A/NKG2-B type II integral membrane protein Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of KLRC1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
PTPRG Biologics Sequence Review Report 2026: Receptor-type tyrosine-protein phosphatase gamma Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
PTPRG Biologics Sequence Review Report 2026: Receptor-type tyrosine-protein phosphatase gamma Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of PTPRG protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →